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The prevalence and prognostic signieaace of silent myocardial
ischemia were prospectively assessed in 217 patients (mean age 57
t 9 years, 83% not
recovering from a first uncomplicated acute
myocardial infarrtla end undergoing a dipyrldamole echocar-
dkrgraphy test before hospital discharge. Clinical, angiograpiek,
esereise eleMrocardiogriephic (ECG) and dipyridamote eehoear-
diographie variables were also examined . Of the 217 patients, 89
had no eehoeardiographicaiy proved dyssyaergy after dipyrida-
mok, whereas 128 had dipyridarde4aduad wall motion abnor-
malities that were silent a
94 (Grortp
1)
and symptomatic in 34
(Croup 119 .
There was no tntergroup difference with respect to dipyrids,
mrletime (i.e., Ike time ftmnansm afmelea mfrenlrdyssynergy:
7 t 3 vs. 8 t 3 min
; p= NS)
; provalene of i ferior myocardial
inraresa (69% ve. 7196 ; p -
NS) ;
ismenx is ECG
changes daring
the Best (83% no . 71% ; p ae NS) ; diabetes (8.5% vs . 6% ; p = NS);
ageing medical therapy; multivessel disease (57% vs. 56%
; p =
NS); and baseline left
ventricular
ejection fraction (5y ± 13% vs.
The prognostic significance of silent ischemia is though( to
vary in different clinical subgroups. Silent ischemia has been
studied in patients with stable and unstable angina (1-6) and,
more recently, in selected patients after myocardial infarc-
tion (7-11). These studies suggest that silent ischemia is
detectable in up to 33% of patients after infarction and
provides a useful adjunct to risk stratification
(11),
In most of
these studies, asymptomatic ischemia has been detected by
use of the standard exercise test or ambulatory electrocar
diogtaphic (ECG) monitoring . Although in many patients ST
segment depression represents myocardial ischemia, false
positive ST depression, especially in postinfarctiun patients
(7), confounds analysis and hence the prognostic value of the
ECG response (12) .
Dipyridamole echocardiography may offer several impor-
tant advantages over conventional stress elcetrocardiog-
rupisy or ambulatory ECG monitoring in assessing the extent
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57 ! 10%: p = NS). There was the no sigailant i erenee
between Group i and Group 11 with respect to wall motion exam
index at pears dlpyr(damale e(sn (1 .77 * 9
.39 on. 1
.70 a 0.36;
p =
NS)
.
Patients were followed up far 24 ± 4 and 25 t 5 months,
respectively (p = NS). LiFe table raallysis revealed ao difference in
unstable angina, eeiefmrdoe and death between the two groups.
A Cox survival wyrsideatined a positive eerocardiogrs after
dipyridamote admilehtrnYca as dhe bat peculator or rardiue
aveats
(chioquaee = 9 .1; p < 0 .000), whereat dipyridarmla
idaced chest
P" showed ao indepmllem predictive value (ch&
square = 2 .7 ; p = N18)
.
Thus, pattemr with wheat ixamta and symptonentie -b,-
had compaealda 1) severity
of elrhrdaced hchemia (as
assessed
by dipyriaamole
time and extent at wail matins ahaor-
matitiec), 2) extent otaimlonrsobieeaooary, artery disease, and 3)
incidence of critical cardiac events .
(IAm Cod Cermol /992 ;79,953-91
of coronary artery disease (13-15) and prognostic stratifica-
tion (16,17) in postinfarction patients with possible silent
ischemia. Echocardiographic monitoring during dipyrida-
mole infusion is more sensitive and specific for the ischemia
response than is ST segment depression analysis (13 .14); it
can define the anatomic location of ischemia (14-16), detect
ischemia in the presence of baseline ECG abnormalities and
allow comparison of the amount of ischemia myocardium
during silent and painful ischemia (13).
The purpose of this study was therefore to prospectively
assess the prevalence and prognostic significance of
dipyeidamote-induced silent ischemia in a group of consec-
utive patients recoveringfrom an uncomplicated acute myo-
cardial infarction. Clinical, angiogiaphic, exercise ECG and
dipyridamole echacardiographic variables were also exam-
ined .
Methods
Study patients. The initial study group consisted of 231
consecutive patients admitted to the coronary care unit
between November 1987 and February 1990 after a first
acute myocardial infarction . The diatuesis of acute infarc-
m35-1o9w9Vs5 .m
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Lion was based on a typical increase and decrease in plasma
creatine boast NIB isocnzyme in the clinical salting of
prolonged chest pain and diagnostic serial FCG changes
.
Patients with avert heart failure, angina
w--,wring
>48 h
after myocardial infarction and age X10 years were not
admitted to the study .
Foartesv purientr were ezrhrded because of a technically
inadequate twodimenaional echocardiogram at rest
. Thus,
217 patients (180 men, 27 women) aged 29 to 70 years (mean
57 ± 91 were enrolled in the study, All gave informed
consent .
Dipyridamole echocardiography and a treadmill exercise
test were performed 8 to 10 days after acute myocardial
infarction
. All ongoing medications, including betn-
adrenergic Mocking agents and nitrates . were continued
during the test. All patients were asked to return for cardiac
catheterization 6 weeks after acute myocardial i nfarction . as
part of an ongoing risk stratification study, and at specified
intervals to our outpatient clinic for follow-up
.
Dipyrldnmole echocardiography. Two-dimensional echo-
cardiography and 12-lead ECG monitoring were performed
in combination with dipyridamole infusion (18) : 0 .56 mglkg
body weight over 4 min, no dose for 4 min and then, if the
test result was still negative, 0 .28 mgIng over 2 min . The
cumulative dose was therefore 0 .84 mgtkg during 10 min
.
Two-dimensional echocardiograms were eotltinnously re-
corded during and up to 10 min after dipyridamole adminis-
tration. Commercially available imaging systems (Hewlett-
Packard mode] 77020 AC, 3 .S Mile transducer and Toshiba
Sunolayer Alfa SSH-160A, 2i and 3.75 MHz transducers)
were used. Aminophylline (701n 240 mg over 1 to 3 min) was
always given, either at the end of a negative test or in the
presence of an obvious new dyssynergy . All echocardio-
grams were analyzed h y two experienced observers who had
no knowledge of treadmill exercise results or angiographic
Findings-
A watt motion scare index was derived for rest and peak
dipyridamole echocardiograms in each patient, The Fell
ventricle was divided into 13 segments (19) . Segmental wall
motion was graded from I to 4 as follows: I = normal,
defined as normal motion at rest, with normal or increased
wall motion (hypcrkincsia) after dipyridamole ; 2 = hypoki-
nelic, defined as marked reduction of endoeasdial msuion ;
3 = akinetic, defined as virtual absence of inward motion :
and 4 = dyskinetic, defined as paradoxic wall motion away
from the center of the left ventricle in systole
. The wall
motion score index was derived by summation of individual
segment scores divided by the number of interpreted seg-
ments
. Inadequately visualized segments were not scored .
A posif(ve jest r-P was linked to detection of transient
asynergy of contraction that was absent or of a lesser degree
in the baseline examination
. We have previously described
the very high interobsercer agreement with diagnosis
achieved in our laboratory (14)
.
For patients with a positive test resteh, we
also recorded
the -'dipyridamole time" in minutes (that is, the time from
1ACC Vol
. 19, Yo. s
April W-PI
the onset of infusion to the development of frank dyssyn-
ergy). For the purpose of the study, we defined dipyrida-
mole-induced silent ischemin as the development of new and
reversible wall motion abnormalities with no angina or
angina equivalent on dipyridamolc echocardiography .
Treadmill exercise test. Patients performed maximal ex-
ercise on a motor-driven treadmill with use of a standard
Bruce protocol . Three simutanneous FCG leads (1, aVF and
V s) were monitored continuously with an oscilloscope at
rest, during exercise and up to 10 min after exercise . A
12-lead ECG, blood pressure and heart rate were recorded
basally and at I min intervals .
Exercise was
conriaoed lairil one of the following end
pains nremred: l) achievement of maximal hear rate
predicted on the basis of age and gender for untrained
subjects ; 2) severe angina; 3) limiting symptoms such as
dyspnea, fatigue, dizziness or leg cramps ; 4) 2!2-mm ST
segment depression ; 5) >10-mm Hg decrease in exercise
systolic blood pressure ; 6) increase in systolic blood pres-
sure to >200 mm Hg ; or 7) appearance of frequent or
complex arrhythmias .
Exercise test results were interpreted by an experienced
cardiologist who did not know the angiographic or dipyrid-
amole echocardiographic findings.
Coronary anglegrophy . Selective coronary angiography
was performed with use of the fudkins or Sones technique .
All angiograms were interpreted without knowledge of re-
salts of dipyridamole echocardiography. Significant coru-
nary stenosis was defined as -75% reduction in the lumen
diameter of coronary vessels.
5'inglr-wanel disease implied significant coronary steno-
sis confined tonne of the three major epicardial vessels or its
branches . Multivessel disease was defined as significant
coronary stenosis in two or three of the major epicardial
vessels or the presence often maia coronary artery disease .
Follow-up. After hospital discharge, patients were re-
ferred to their private physician, who regulated therapy . No
attempt was made to standardize therapy . All patients were
asked to return to our outpatient clinic for evaluation by the
principal investigator 3 months after discharge and annually
thereafter . For those patients not returns; to the dine at
the designated time, follow-up information was collected by
telephone interview .
Because the study grump is a low risk group, lice mortality
or reinfarction rate was anticipated to be low; therefore, the
progression of symptomatic coronary artery dsease as mea-
sured by the development of unstable ang'na was also an
anticipated endpoint. We decided in advance that coronary
angioplasty or coronary bypass surgery would not be con-
sidered an event . Because we anticipated that the results of
dipyridamole echocardiography or angiography might con-
tribute to the decision to perform angioplasty or surgery, the
follow-up period was terminated in patients who underwent
angioplasty or surgery . Cardiac death was defined as sudden
death (occurring within I h of the onset of symptoms) cr
death associated with cardiac complications for which the
5OLOGNESE ET AL.
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Table 1 . Comparison of Clinical Variables in Group I and
Group 1C
"Noneofthe vadables differrd de-nidcanfly between groups . AM1= acute
myocardial infarction : Group I = patients wish silent ischemia and Group
II =
pd- with enahia, Acting, Waitiv- dipyridamole echocardiography teau
patient had been hospitalized . For purposes of analysis, only
one event. the most serious, was tabulated for each patient .
Stalistical anat)sis. Data analysis was performed with the
Student r test for continued data and the chi-square test for
uncontinuous data, with the Yates correction as appropriate .
Results are expressed as mean values - SD or as a percent.
Cumulative survival curves were calculated by means of the
product-limit method of Kaplan and Meier. Statistical differ.
ences between curves were assessed with the log-rank or
Mantel-Haenseel test . The raqutred Ievel of significance was
p < 0.05 . Values are presented as mean vanes
st
SD unless
otherwise indicated.
The individual effect ofcertain variables on survival cans
evaluated with the use of the Cots regression model (BMPI)
P2L, Department of Biomathematics, University of Califor-
nia at :.off Angeles) . According to a stepwise selection
process, variables were entered, or removed . from the
regression equation on the basis of a computed significance
probability (maximized partial likelihood ratio) .
Variables examined were age, gender, infarct location,
rest wall motion score index, positive echocardiogrdphic
findings during the dipyridamole test, chest pain during the
test. ST-T changes during the test and wall motion score
index at peak dipyridamole effect. For patients with a
positive dipyridamole echocardiographic study, two subsets
were also considered: I) patients with a positive echocardio-
graphic result within 4 min after the low dose dipyridamole
infusion (0.56 mglkg during 4 min); and 2) patients with a
positive result after fall dose dipyridamole infusion
(0.54
mg/kg
during 10 min).
For the subset of 194 patiems in whom data on the
treadmill exercise test, coronary angiogsphy and ejection
fraction by ventrirxdogeaphy were also available, these var-
iahles were examined as wcll-
Results
Patient characteristics (Table 1), All patients were asymp-
tomatie at me time of dipyridamole echocardiography . Of
Table L Comparison of Ansiooraphic Variables in Group I an!
Group 11"
-None of the anglographn 5ananle5 mitered srgnhhcanlly
6rlw'col gaups.
LAO - left anterior desrending eoranary artery : I .Cy = ten circamdex
narv artery : LVEF = left ventricular
ejection
fracttea : RCA = ngtet
coronary artery. Deflion of groups as in
Table
1 .
the 217 patients
. 89 (41%) had a negative dipyridamole
echocardiography test result. Of the 128 (f9%) with a posi-
tive test result, 94 (43%) had no angina or angina equivalent
(Group 1
. silent ischemia) and 34 (16%) experienced angina
during the test (Group II .
angina)-
The silent ischemia and
angina groups are compared with respect to clinical variables
in Table 1
. No difference was observed between the groups
with respect to age, gender, presence of diabetes, ongoing
medical therapy or site of myocardial infarction .
Treadmill exercise testing . All hut 6 of the 217 patients
performed a symptom-limited treadmill exercise test ; the
result was positive in 80 patients (38%). Fourteen of the 80
patients developed typical angina during exercise; all had
diagnostic ST segment changes .
Angiographic irlitgs (Table 2). There was no difference
between Group I and Group H with respect to baseline
ejection fraction, the frequency of one-, two- and three-
vessol disease, the occurrence of significant disease in any
specific vessel (left anterior descending, left circumflex or
right coronary artery) and the prevalence of infarction
related or not related to the left anterior descending coronary
artery .
Dipyridamele ecboeardiogaphy variables . There was no
significant difference between the two groups with respect to
dipyridamole time (7 - 3 vs. 8 m 3 min ; p = NS), percent of
patients with ischemic ECG changes (83% vs. 71% . p = NS)
or percent of patients with multivessel wall motion abnor-
malities (38% vs- 42%; p = NS).
To compare the extent of wall motion abnormalities
between the two groups, a wall motion scare index was
derived for each patient at rest and at peak dipyridamole
effect . There was no significant difference between Group I
and Group 11 with respect to wall motion score index at peak
dipyridamole effect (1 .77 m 0 .39 vs. 1 .78 ± 0.36 ; p = NS),
Nineh•-five of
the 217 peHenrs had both dipyridamnle-
induced transient dyssynergy and ischemir ST segment
depression . Of these, 67 P1%) had silent ischemia and 28
(29%) had angina pectoris, Within this subgroup, those with
silent ischemia or angina had similar valves for time of onset .
duration and location of ST segment depression . Also, there
Group I
In - 94)
Group 11
In - 341
Age (yr) (me . *_ SD) 57 .4 s 8
53.8 x 10
Main 1%) 85 85
niabelcs (%) 8
.5 6
Bete ,Ewaern 1%)
9 28
Nitrates (vc)
32 47
CakiumatOgonisul%r)
21 20
Site
of AMI 1%I
Anterior
31 29
Inferior
69
71
Group I
In -941
Gmup ll
1n=341
Gur-vosuti Sister 57!! 23 24
T---I disa
.ct47
% -
Three-•..-el dsase l!k1 '_I at
LVEF P.rrl Imean s SD) 56 .?
-
13 569 z 10
LAD disease PI 61 62
LC,, disease 1h) 61 4a
RCA d- e 191 53 70
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Table 3. Incidence of Clinical Events and Revasculadzation
Procedures in 89 Patiunis With a Negative Dipyridamde
Echvcardiagraphy Test Resvlt and i a file Two Groups of Patients
With kJ uequiseca)1sctejnia During Dipyridatnule Echccardiography
'p < 0.05 versus other groups; other intergroup differences were not
sianiacanl .
CARD =
coronary artery bypass grating ; PICA = percutaneous
transluminal coronary angioplasty . Definition ofgroups as in Table I .
was no difference in dipyridamole time and wall motion
score index at peak dipyridamole efreet
.
Finally, patients in Group I and Group 11 had a similar
prevalence of exercise-induced ischemia (44% vs . 50%; p =
NS), whereas exercise-induced angina was more frequent,
although not significan1y so, in Group 11 (5% vs . 14% ; p =
NS) .
Clhrdeul outcome (Table 3) . Patients in Group I and Group
lI were followed up for 24 :t 4 and 25 ± 5 months,
respectively (p = NS) . The incidence of critical cardiac
events in both groups and among patients with a negative
dipyridamole echocardiography test result during the fol-
low-up period is shown in Table 3 . Patients with a negative
dipyridamole echocardiography test result had a markedly
lower incidence of cardiac events (Fig. 1). There were one
death and two reinfarctions in the angina group compared
with three deaths and four reinfaretions in the silent ischemia
group (p = NS for both events). Unstable angina requiring
JACC Vol . 19. No. 5
April 15992 :553-7
hospitalization occurred in 26% of patients in Group I
compared with 24% of patients in Group 11 (p - NS)
.
Grouping together death, recurrent myocardial infarction
and unstable angina yielded a total of 12 events in the 34
patients of the angina group compared with 30 events
in the
94 patients of the silent ischemia group (35% vs . 32% ; e
NS) .
Survival . Event-free survival curves, in which unstable
angina, reinfarction and death were end points, did not differ
statistically in the two groups (30
t
5% in Group I vs . 70 t
10% in Group 11 at 12 months and 72 t 5% in Group I vs . 67
t 10% in Group 11 at 24 months), whereas patients with a
negative dipyridamole echocardiography test result had a
higher event-free survival rate (92 ± 3% at 12 months and 99
t 5% at 24 months ; Fig . 1).
Revascularizalton rate. This rate, actuarially deter-
mined, for the patients with a negative dipyridamole echo-
cardiography test result and patients in Group I and Group 11
is depicted in Figure 2 (4 t 2% vs . 22
t
5% vs . 30 *- 6% at
12 months ; and 4 ± 2% vs. 24 -A 5% vs . 30 t 6% at 24
months). Revascelarization procedures were performed in a
greater proportion of patients with angina, although Cats
difference was not significant, and most procedures were
done during the ist 6 months after the dipyridamole echo-
cardiography study .
ProRnasde farrors . The univariate prognostic factors are
shown in Table 4. The most important predictor was the
result of the dipyridamole echocardiography test . Using the
Cox model, we found that the significant independent pre-
lfictces of future cardiac events were a positive dipyridamole
echocardiography test (p < 0
.003
; relative risk ratio 2.1) and
gender (p < 0.03 ; relative risk ratio 1
.7) (Table 5).
In the subset of 194 patients in whom cardiac catheter-
ization and treadmill exercise test data were also available,
the univariate analysis is shown in Table 6 . The most
important predictor was the result of dipyridamole echacar-
Figure 1
. Cumulative event-free survival curves for pa-
tients with a negntive dipyridamole eehecanliography
test (DST-ANG-), a positive dipyridamole cchocer-
diography test without angina (DET+ANG- ; Grtup 1)
and a positive dipyridamole eehoeardiography test with
angina (DET+ANG+ ; Group 11)
. These curves are not
statistically different for Group I and Group D, whereas
patients with negative dipyridamole echocardiography
had a
significantly
higher rate of event-free survival in
comparison with the rate in the other two groups .
Negative
Test Resoh
(n - 99)
Group I
In = 94)
Group it
In = 341
Clinic I rvcna,
Ilnslablcangina 7(8%)' 23(24%) 9424%)
Rcinf rnlinn I (1%) 4(4948 216%7
12x111 1(1%) 3(30) 113%0
Total events 9 (10%)' 30(32%) 12 (32%)
Revascularization procedures
CABG 2 (2%)' 15 (16%) 8 (2390)
PICA 3090 ' 77%() 3 (9R)
]ACC Vol~ 19, No . 5
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Figure 2. Revasculadzation procedures (coronary artery
bypass graft surgery and coronary angioplastyl performed
in 89 patients with a negative dipyddamolc echocardiog-
raphy test result (DET-ANG-), 34 patients with ischemia
and no angina IDET+ANG-1 and 94 patients with ischemia
and angina (DET+ANG+) during dipyridarralo oah ar-
diography .
diography, followed by eieclion fraction, gender and results
of coronary arteriography (number of diseased vessels)
.
With stepwise regression analysis, only a positive echocar-
diographie result after dipyridamole administration was an
independent predictor of cardiac events (chi-square 7 .6; p c
0.006; relative risk ratio 1 .6), while dipyridamole induced
chest pain showed no independent predictive value (chi
square = 2
.7; p = NS)
.
Discussion
Silent Ischemia, Silent ischemia is of prognostic rele-
vance in patients with asymptonatic (1), stable (2-4)
or
unstable (5,6) coronary artery disease
. The prognostic sig-
nificance of silent ischemia after infarctior. is less clear .
Some recent studies suggest that silent ischemia on ambula-
tory ECG monitoring 48-10) or exercise testing (7,20) may
provide a useful adjunct (o 'isk stratification in postinfarc-
tion patients . However, the functional expression of silent
ischemia as detected by stress echocardiography, which may
be a poweriui predictor ui lung-tern, progas.s l:5,17,21--
23), has not yet been addressed .
Table 4,
Univariate Predictors 01 Prognosis
6OLOGNESE Er AL.
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ro_
x
so_
All values ore appmxiuntr eel refer to lb. pedicfrve vei,e of exh
variable tried separately to a Cns pNpmticnal harard model . DET -
dipyridmrale eckoeardiopaphy ten : ECG - deOraeardiagranr WMSI -
wall motion 590ev index.
0 13 en ao
Our study attempted to assess the prevalence and the
prognostic significance of silent ischemia as defined by
dipyddamole-induced reversible wall motion abnormalities
in patients recovering from an uncomplicated acute myocar-
dial infarction and to identify which variables play a role in
influencing
whether angina does or does not occur.
The major findings
of our study were : 1) the prevalence
rate of silent ischemia was rather high during the dipyrida-
mole nchocardiesgaphy test performed early after uncompli-
cated acute infarction; 2) there was no Significant difference
in time of onset and extent of dipyridamole-weed ischemia
between the angina and silent ischemia. groups; 3) patients
with silent ischemia and those with angina bad a similar
extent of angiographic coronary artery disease ; and 4) the
presence or absence of angina during a dipyridamole echo-
cardiography test positive for ischemia is not an independent
risk factor for a poor prognosis .
Prevalence d sfkat bbemin . In this prospective study,
94 (41%) of the 217 patients had silent isehcmia on dipyrid-
amole echocardiography, a higher proportion than the pre-
viaa9ly rape . .^ed tsadt cf 23% to 27% fen postinfarction
exercise-induced silent ischemia (7,18) and similar to the
29% to 46% incidence rate of silent spontaneous episodes
detected by ambulatory ECG monitoring (5-20). Because
the mechanism of silent ischemia is not understood (4), the
reason for the higher rate of dipy eidamole-induced ischemia
Table t. Significant Predictors of Cardiac Events According to a
Stepwise
Retressiofl Model
Ck-Squxe P Value Relative Risk
Posiive DIET 9.1 0.003 21
Gender 45 0.03 1.7
Each ehi.,q - and p vruc is a rensi[c of [he unpin-amen[ flat oh
ackcted Variable sake, ie a Radel eoalanitg all other slrdaeaoe variables.
TM relative risk is the indepelr nit risk of. ardin even[ that is assoented
null a varia9k. Abhnevininn as ur Table a
Qd .gl>ere pValue
Positive DET 91 aam
EECcbaugeaduringDET 78 0.90$
Gender 4.3 0.03
rwtWMSI 3.2 Ns
WMSI u peak dipyridamde effort 2.6 NS
Pain daring GET 2.h NS
Age 1 .7 NS
(morel location 0.2 NS
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Table 6,
Univasiate Predictors of Proonusis in 194 Patients With
Cardiac Catheterization end Treadmill Test Data
Abbrevnlions as in'IaOn 1.
is not clear. However. because a wall motion abnormality as
a marker of ischemia is more sensitive and specific than is ST
segment depression, it may be argued that studies that have
relied solely on ECO criteria have probably greatly under-
estimated the number of patients with silent ischemia .
"Silent" dipyridamole.induced wall motion abaormJrilies .
The significance of painless dipyridamale-induced wall au-
lion abnormalities in patients recovering from an acute
myocardial infarction has not yet been evaluated . The high
prevalence of silent ischemia in this study, as defined by
dipyridamole echocardiographic criteria, has important clin-
ical implications . Using a stress-induced reversible left ven-
tricular regional wall motion abnormality as a marker of
ischemia, we were able to include patients who might not
have been identified by conventional exercise testing and
excluded patients with a potentially false positive ECG
response . In fact, although in our series 128 patients exhib-
ited ischemia by dipyridamote echocardiography, 48 patients
(22%) included in the study in the group with ischemia would
have been excluded if ST segment changes alone during
exercise testing had been utilized for study group inclusion .
hipyrtdamole cohere'deographie data aiso permitted as-
sessment of the extent of M e ischemic response, which
cannot be achieved by analysis of the ST segment alone . The
present study clearly demonstrates a similar amount of
jeopardized ischemic myocardium on dipyridamole echocar-
diography whether or unit there is accompanying angina or
ST segment depression . Other recent studies (24-26) that
amp.oyr:d a:yecardial perfusion imaging to study the amount
of myocardium in jeopardy in patients with silent ischemia
tad stable coronary artery disease found no difference in the
number of redistribution defects per patient between those
wish silent ischemia and those with exercise angina . Simi-
larly. Wohlgelernter et al
. (27) reported that asymptumatic
and symptomatic episodes of ischemia caused by angio-
plasty balloon inflation were associated with a similar reduc-
tion in segmental
and global left ventricular function and
were equal in duration . Overall these data do not support the
possibility that ischemia of decreased severity accounts for
the absence of symptoms and are in agreement with our
findings . This is not surprising, since the extent and severity
of the perfusion defects should be mirrored by the extent and
severity of the wall motion abnormalities, as shown by
experimental and clinical data .
Clinical and angiagraphie variables . The clinical charac-
teristics of the silent and painld ischemia groups were
similar . We found no differences with respect to age, gender,
ongoing medical therapy and site of myocardial iniarcticn .
These findings are similar to those reported in previous
studies
(7,20) .
When we examined the ischemic response in relation to
angfogrephic extent of coronary artery disease, we found no
difference in the percent of patients with single and multi
vessel disease or in baseline left ventricular ejection fraction
between the silent ischemia and angina groups . These find-
ings are consistent with prior data on postinfarction patients
(7,28).
Clinical outcome. In this study, silent ischemia during
dipyridamole echocardiography carried a similar risk of
unstable angina, reinfaretion and cardiac death as did symp .
tomatic ischemia . These findings are in agreement with
previous studies employing ambulatory ECG monitoring (9),
exercise testing (7) and perfusion imaging (25) . In light of the
comparable amounts of ischemia, the similar prognosis of
postinfarction patients with and without angina is not sir.
prising because it should be the amount of myocardium at
risk that determines survival, independent of whether chest
pain is induced on a particular stress test
.
Our data also confirm and expand previous observations
by several groups on the dramatic prognostic impact of a
dipy'tidamote echocardiography lest result in different pa-
tients subsets, including those with early uncomplicated
myocardial infarction (16,17) or stable angina (21) and those
undergoing coronary angioplasty (29) m peripheral vascular
surgery (30) .
Conelusions . Our findings indicate a high prevalence of
silent iseheenia as defined by dipytidamole echocardio-
graphic criteria early after uncomplicated acute myocardial
infarction. We found that patients with silent and sympto-
matic dipyridamole-induced ischemia had a comparable time
of onset of ischemia, a similar extent of dipyridamole-
induced wall motion abnormalities and a similar extent of
angiographic coronary artery disease. The presence or ab •
sence of angina during a dipyridamole
echocardiography
test
positive for ischemia was not an independent risk factor for
a poor prognosis, whereas dipyridamole-induced dyssyncrgy
was a strong predictor of adverse outcome. Thus, the
management of postinfarction patients . even those in a low
risk group. must focus on the treatment of ischemia, regard-
less ot'symptoms .
We are grateful to Andrea Giordtao . PhD for invalolble advice ro c:ming
sl'ddsrtaai analyses .
Chi-Sgaoe
P Vxlue
Podtlve VET 7.6 0.005
ECG changes dining DET 6.4 0.01
Ejection fraction
4.5
0 .03
Gender
3 .9 0.05
Coronary a.e ui ruphk findings
Rest WMSI
Pain during TAT
WMSI at peak dipylidarrole effect
Ape
trf r laation
ECG changes drains exercise its,
3 .4
2 .5
2.2
1 .6
1 .1
0.2
0.1
0.06
NS
NS
NS
NS
NS
NS
Pain during exercse test 0.06 NS
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